BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
The protective potential of selected lactic acid bacteria against the most common contaminants in various types of cheese in Egypt. ✅
Go to Publication ✅
Heliyon (Heliyon ) Vol: 5 Issue 3 Pages: e01362 Pub: 2019 Mar Epub: 2019 Mar 19 Authors Al-Gamal MS , Ibrahim GA , Sharaf OM , Radwan AA , Dabiza NM , Youssef AM , El-Ssayad MF , |
|
|
The protective potential of selected lactic acid bacteria against the most common contaminants in various types of cheese in Egypt. ✅
Go to Publication ✅
Heliyon (Heliyon ) Vol: 5 Issue 3 Pages: e01362 Pub: 2019 Mar Epub: 2019 Mar 19 Authors Al-Gamal MS , Ibrahim GA , Sharaf OM , Radwan AA , Dabiza NM , Youssef AM , El-Ssayad MF , |
|
|
The protective potential of selected lactic acid bacteria against the most common contaminants in various types of cheese in Egypt. ✅
Go to Publication ✅
Heliyon (Heliyon ) Vol: 5 Issue 3 Pages: e01362 Pub: 2019 Mar Epub: 2019 Mar 19 Authors Al-Gamal MS , Ibrahim GA , Sharaf OM , Radwan AA , Dabiza NM , Youssef AM , El-Ssayad MF , |
|
|
Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats. ✅
Go to Publication ✅
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 103 Issue 23-24 Pages: 9673-9686 Pub: 2019 Dec Epub: 2019 Nov 12 Authors Wang Q , Lv L , Jiang H , Wang K , Yan R , Li Y , Ye J , Wu J , Wang Q , Bian X , Yang L , Jiang X , Xie J , Lu Y , Shen J , Li L , |
|
|
Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats. ✅
Go to Publication ✅
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 103 Issue 23-24 Pages: 9673-9686 Pub: 2019 Dec Epub: 2019 Nov 12 Authors Wang Q , Lv L , Jiang H , Wang K , Yan R , Li Y , Ye J , Wu J , Wang Q , Bian X , Yang L , Jiang X , Xie J , Lu Y , Shen J , Li L , |
|
|
Lactobacillus helveticus R0052 alleviates liver injury by modulating gut microbiome and metabolome in D-galactosamine-treated rats. ✅
Go to Publication ✅
Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 103 Issue 23-24 Pages: 9673-9686 Pub: 2019 Dec Epub: 2019 Nov 12 Authors Wang Q , Lv L , Jiang H , Wang K , Yan R , Li Y , Ye J , Wu J , Wang Q , Bian X , Yang L , Jiang X , Xie J , Lu Y , Shen J , Li L , |
|
|
Lactobacillus sp. improved microbiota and metabolite profiles of aging rats. ✅
Go to Publication ✅
Pharmacological research (Pharmacol Res ) Vol: 146 Issue Pages: 104312 Pub: 2019 Aug Epub: 2019 Jun 14 Authors Hor YY , Lew LC , Jaafar MH , Lau AS , Ong JS , Kato T , Nakanishi Y , Azzam G , Azlan A , Ohno H , Liong MT , |
|
|
Long-term intake of Lactobacillus helveticus enhances bioavailability of omega-3 fatty acids in the mouse retina. ✅
Go to Publication ✅
NPJ biofilms and microbiomes (NPJ Biofilms Microbiomes ) Vol: 10 Issue 1 Pages: 4 Pub: 2024 Jan 18 Epub: 2024 Jan 18 Authors Lapaquette P , Terrat S , Proukhnitzky L , Martine L , Grégoire S , Buteau B , Cabaret S , Rieu A , Bermúdez-Humarán LG , Gabrielle PH , Creuzot-Garcher C , Berdeaux O , Acar N , Bringer MA , |
|
|
Long-term intake of Lactobacillus helveticus enhances bioavailability of omega-3 fatty acids in the mouse retina. ✅
Go to Publication ✅
NPJ biofilms and microbiomes (NPJ Biofilms Microbiomes ) Vol: 10 Issue 1 Pages: 4 Pub: 2024 Jan 18 Epub: 2024 Jan 18 Authors Lapaquette P , Terrat S , Proukhnitzky L , Martine L , Grégoire S , Buteau B , Cabaret S , Rieu A , Bermúdez-Humarán LG , Gabrielle PH , Creuzot-Garcher C , Berdeaux O , Acar N , Bringer MA , |
|
|
Health-Promoting Properties of Lactobacillus helveticus. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 3 Issue Pages: 392 Pub: 2012 Epub: 2012 Nov 19 Authors Taverniti V , Guglielmetti S , |
|
|
Health-Promoting Properties of Lactobacillus helveticus. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 3 Issue Pages: 392 Pub: 2012 Epub: 2012 Nov 19 Authors Taverniti V , Guglielmetti S , |
|
|
Health-Promoting Properties of Lactobacillus helveticus. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 3 Issue Pages: 392 Pub: 2012 Epub: 2012 Nov 19 Authors Taverniti V , Guglielmetti S , |
|
|
Health-Promoting Properties of Lactobacillus helveticus. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 3 Issue Pages: 392 Pub: 2012 Epub: 2012 Nov 19 Authors Taverniti V , Guglielmetti S , |
|
|
Health-Promoting Properties of Lactobacillus helveticus. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 3 Issue Pages: 392 Pub: 2012 Epub: 2012 Nov 19 Authors Taverniti V , Guglielmetti S , |
|
|
Health-Promoting Properties of Lactobacillus helveticus. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 3 Issue Pages: 392 Pub: 2012 Epub: 2012 Nov 19 Authors Taverniti V , Guglielmetti S , |
|
|
Health-Promoting Properties of Lactobacillus helveticus. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 3 Issue Pages: 392 Pub: 2012 Epub: 2012 Nov 19 Authors Taverniti V , Guglielmetti S , |
|
|
Daily intake of Lactobacillus alleviates autistic-like behaviors by ameliorating the 5-hydroxytryptamine metabolic disorder in VPA-treated rats during weaning and sexual maturation. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 12 Issue 6 Pages: 2591-2604 Pub: 2021 Mar 21 Epub: 2021 Feb 25 Authors Kong Q , Wang B , Tian P , Li X , Zhao J , Zhang H , Chen W , Wang G , |
|
|
Candidate-Probiotic Lactobacilli and Their Postbiotics as Health-Benefit Promoters. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 12 Issue 9 Pages: Pub: 2024 Sep 19 Epub: 2024 Sep 19 Authors Dobreva L , Atanasova N , Donchev P , Krumova E , Abrashev R , Karakirova Y , Mladenova R , Tolchkov V , Ralchev N , Dishliyska V , Danova S , |
|
|
Candidate-Probiotic Lactobacilli and Their Postbiotics as Health-Benefit Promoters. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 12 Issue 9 Pages: Pub: 2024 Sep 19 Epub: 2024 Sep 19 Authors Dobreva L , Atanasova N , Donchev P , Krumova E , Abrashev R , Karakirova Y , Mladenova R , Tolchkov V , Ralchev N , Dishliyska V , Danova S , |
|
|
Candidate-Probiotic Lactobacilli and Their Postbiotics as Health-Benefit Promoters. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 12 Issue 9 Pages: Pub: 2024 Sep 19 Epub: 2024 Sep 19 Authors Dobreva L , Atanasova N , Donchev P , Krumova E , Abrashev R , Karakirova Y , Mladenova R , Tolchkov V , Ralchev N , Dishliyska V , Danova S , |
|
|
Lactobacillales derived from traditional Xizang dairy products improve insomnia and restore neurotransmitter-metabolic profiles via gut microbiota in PCPA-induced mice. ✅
Go to Publication ✅
Microbiological research (Microbiol Res ) Vol: 300 Issue Pages: 128276 Pub: 2025 Jul 8 Epub: 2025 Jul 8 Authors Li P , Yang L , Shao X , Zou Z , Shi H , Sun Y , Wu X , Li Z , Li Y , Li Z , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
